There is real and growing concern that global action to address drug-resistant infections is not happening at the scale and urgency needed.

Are we gambling away the bedrock of modern medicine and putting the world at serious risk of a post-antibiotic era? Is access to life-saving drugs being jeopardized through excessive misuse, unenforceable policies, and a failure to effectively communicate the risk of antimicrobial resistance (AMR) to decision-makers and society at large?

The RADAAR Consortium invites you to The Gamechangers, a series of six AMR policy webinars, which are  part of a wider critical reflection and engagement initiative to influence contemporary AMR policy by strategically leveraging data to answer 5 key questions:

Where are we today? Where do we need to go? How do we get there? What works? What’s it going to cost?

Register for The Gamechangers webinar series below!

Learn more about each webinar’s speakers, discussants, and moderators here.

Stopping AMR: Leveraging Data to Drive Policy

Webinar 1 | Critical Reflections: The Global AMR Response

September 16, 17:00-18:00 Korea Standard Time (8:00-9:00 GMT)

The first webinar featured Lord Jim O’Neill, former Chair of the AMR Review, as the Inaugural Speaker. Subsequent webinars—during September/October 2021—will feature leading scientists, economists, policy experts, activists, and the private sector. A wide range of AMR policy topics will be covered in depth, including prevention and control strategies, new surveillance methods and technologies such as Whole Genome Sequencing, linking the technical and social dimensions of AMR, and the potential of artificial intelligence and machine learning algorithms.

The experts and thought leaders featured in this webinar will offer new insights and raise provocative questions towards inspiring bold and creative approaches for stopping the emergence and spread of drug-resistant infections.

Stopping AMR: Leveraging Data to Drive Policy

Webinar 2 | AMR Surveillance: Past, Present, and the Future

September 23, 17:00-18:30 Korea Standard Time (8:00-9:30 GMT)

Speakers:

• Dr. John Stelling, Brigham and Women’s Hospital
• Dr. David Aanensen, Big Data Institute, Oxford University

Discussant/Moderator:

• Dr. Pascale Ondoa, African Society of Laboratory Medicine

Stopping AMR: Leveraging Data to Drive Policy

Webinar 3 | Linking the ‘technical’ and the ‘social’

October 8, 17:00-18:30 Korea Standard Time (8:00-9:30 GMT)

Speaker:

• Prof. Olivier Rubin, DSSB, Roskilde University
• Prof. Clare Chandler, LSHTM

Discussant/Moderator:

• Dr. Will Parks, UNICEF

Stopping AMR: Leveraging Data to Drive Policy

Webinar 4 | The Public and Private Sectors: Points of Intersection, Points of Departure

October 15, 17:00-18:30 Korea Standard Time (8:00-9:30 GMT)

Speakers:

• Bruce Altevogt, Pfizer
• Dr. Catrin Moore, Global Research on Antimicrobial Resistance (GRAM) Project

Discussant/Moderator:

• Dr. Gemma Buckland Merrett, Wellcome Trust

Stopping AMR: Leveraging Data to Drive Policy

Webinar 5 | One Health and AMR Surveillance: Approaches and Options

October 22, 17:00-18:30 Korea Standard Time (8:00-9:30 GMT)

Speakers:

• Dr. Frank Møller Aarestrup, Technical University of Denmark
• Dr. Thomas van Boeckel, ETH Zurich

Discussant/Moderator:

• Prof. Sabiha Essack, University of KwaZulu-Natal

Stopping AMR: Leveraging Data to Drive Policy

Webinar 6 | Disruptive Methodologies: Artificial Intelligence, Machine Learning, and AMR

October 28, 21:00-22:30 Korea Standard Time (12:00-13:30 GMT)

Speakers:

• Dr. Jonathan Stokes, MacMaster University
• Dr. Brian Hie, Stanford University

Discussant/Moderator:

• Dr. John Stelling, Brigham and Women’s Hospital

About the RADAAR Consortium

The ‘Regional Antimicrobial resistance Data Analysis for Advocacy, Response and policy’ (RADAAR) project aims to catalyse a sustained demand among decision-makers for high-quality information and data-sharing for use in global AMR planning, policy and advocacy. The lead grantee is the International Vaccine Institute (IVI) based in Seoul, Republic of Korea and supported by The Fleming Fund.

Learn more here.